TuHURA Biosciences
HURA
10 hedge funds and large institutions have $448K invested in TuHURA Biosciences in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
136% more capital invested
Capital invested by funds: $190K → $448K (+$259K)
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
25% more funds holding
Funds holding: 8 → 10 (+2)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$92.6K |
| 2 |
IIA
IPG Investment Advisors
San Diego,
California
|
+$30.2K |
| 3 |
Two Sigma Investments
New York
|
+$24.2K |
| 4 |
Goldman Sachs
New York
|
+$22.1K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$47K |
| 2 |
Barclays
London,
United Kingdom
|
-$25K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$16K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.03K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $241K | +$92.6K | +46 | +88% |
|
|
RE
2
RBC Europe
London,
United Kingdom
| $42K | – | – | – |
|
|
IIA
3
IPG Investment Advisors
San Diego,
California
| $36.4K | +$30.2K | +15 | New |
|
|
4
Two Sigma Investments
New York
| $29K | +$24.2K | +12 | New |
|
|
5
Goldman Sachs
New York
| $28K | +$22.1K | +11 | New |
|
|
6
Vanguard Group
Malvern,
Pennsylvania
| $25K | +$20.1K | +10 | New |
|
7
State Street
Boston,
Massachusetts
| $19K | +$16.1K | +8 | New |
|
8
Northern Trust
Chicago,
Illinois
| $17K | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| $7K | -$4.03K | -2 | -40% |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $3K | +$2.01K | +1 | New |
|
|
TFS
11
TrustCore Financial Services
Brentwood,
Tennessee
| $1K | – | – | – |
|
|
VF
12
Virtu Financial
New York
| – | -$47K | -39 | Closed |
|
|
13
Barclays
London,
United Kingdom
| – | -$25K | -21 | Closed |
|
|
14
Citadel Advisors
Miami,
Florida
| – | -$16K | -13 | Closed |
|
|
15
Osaic Holdings
Scottsdale,
Arizona
| – | -$3K | -2 | Closed |
|
HURA Hedge Fund Activity: Q3 2020 in Review
10 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q3 2020, worth a combined $448K — up 136% from $190K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new HURA positions and 4 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $92.6K. The largest seller was Virtu Financial, exiting entirely with an estimated $47K sold.
- 10 institutional investors held TuHURA Biosciences (HURA) as of Q3 2020, up from 8 in Q2 2020.
- Funds reported $448K of TuHURA Biosciences stock for Q3 2020, up 136% quarter-over-quarter.
- 6 funds opened new TuHURA Biosciences positions in Q3 2020 and 4 closed out, a net change of +2 holders.
- The largest TuHURA Biosciences buyer in Q3 2020 was Renaissance Technologies, an estimated $92.6K added.
- The largest TuHURA Biosciences seller in Q3 2020 was Virtu Financial, an estimated $47K sold.
Based on aggregated 13F filings for Q3 2020.